Article (Scientific journals)
I-Kappa-B kinase-epsilon activates nuclear factor-kappa B and STAT5B and supports glioblastoma growth but amlexanox shows little therapeutic potential in these tumors
DUBOIS, Nadège; Berendsen, Sharon; HENRY, Aurélie et al.
2018In Cancer Translational Medicine, 4 (1), p. 1-8
Peer Reviewed verified by ORBi
 

Files


Full Text
CancerTranslMed411-3741341_102333.pdf
Publisher postprint (1.07 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
DUBOIS, Nadège  ;  Centre Hospitalier Universitaire de Liège - CHU > Département ULiège > Faculté de médecine
Berendsen, Sharon;  Department of Neurology and Neurosurgery, Rudolf Magnus Brain Center, University Medical Center of Utrecht, 100 Leuvenlaan, 3584 CX Utrecht, The Netherlands
HENRY, Aurélie ;  Centre Hospitalier Universitaire de Liège - CHU > Unilab > Unité de laboratoire constitutionnel - prénatal
Nguyen, Minh
Bours, Vincent ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Génétique humaine
Robe, Pierre Alain;  Department of Neurology and Neurosurgery, Rudolf Magnus Brain Center, University Medical Center of Utrecht, 100 Leuvenlaan, 3584 CX Utrecht, The Netherlands
Language :
English
Title :
I-Kappa-B kinase-epsilon activates nuclear factor-kappa B and STAT5B and supports glioblastoma growth but amlexanox shows little therapeutic potential in these tumors
Publication date :
26 February 2018
Journal title :
Cancer Translational Medicine
ISSN :
2395-3977
eISSN :
2395-3012
Publisher :
Wolters Kluwer Medknow Publications, India
Volume :
4
Issue :
1
Pages :
1-8
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 April 2019

Statistics


Number of views
47 (11 by ULiège)
Number of downloads
4 (4 by ULiège)

OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi